LB0002 Safety and Tolerability of Arimoclomol in Patients with Sporadic Inclusion Body Myositis: A Randomised, Double-Blind, Placebo-Controlled, Phase IIa Proof-of-Concept Trial

Machado, P.; Miller, A.; Herbelin, L.; He, J.; Noel, J.; Wang, Y.; McVey, A. L.; Pasnoor, M.; Gallagher, P.; Statland, J.; Brady, S.; Lu, C.- H.; Kalmar, B.; Sethi, H.; Samandouras, G.; Holton, J.; Greensmith, L.; Barohn, R. J.; Hanna, M. G.; Dimachkie, M. M.

期刊名称Annals of the Rheumatic Diseases
作者Machado, P.; Miller, A.; Herbelin, L.; He, J.; Noel, J.; Wang, Y.; McVey, A. L.; Pasnoor, M.; Gallagher, P.; Statland, J.; Brady, S.; Lu, C.- H.; Kalmar, B.; Sethi, H.; Samandouras, G.; Holton, J.; Greensmith, L.; Barohn, R. J.; Hanna, M. G.; Dimachkie, M. M.
卷第72卷
印刷ISSN0003-4967
文件大小228.44KB
发表时间2013-06-01
DOI10.1136/annrheumdis-2013-eular.527

发现好书期刊，享受阅读乐趣

LB0002 Safety and Tolerability of Arimoclomol in Patients with Sporadic Inclusion Body Myositis: A Randomised, Double-Blind, Placebo-Controlled, Phase IIa Proof-of-Concept Trial